Forecasted revenue of mRNA market revenue worldwide 2021-2035

Published by
Matej Mikulic,
Sep 16, 2021
In 2021, revenues of mRNA products will come only from COVID-19 vaccines, forecasted to reach around 21 billion U.S. dollars worldwide. This statistic illustrates the forecasted revenue of mRNA products worldwide from 2021 to 2035.

Forecasted mRNA product revenue worldwide from 2021 to 2035* (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2021

Region

Worldwide

Survey time period

as of September 2021

Supplementary notes

* Risk-adjusted revenues. The source did not provide forecasts for some years.
** 2021 figures represent only approximate COVID-19 vaccine sales.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " mRNA technology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you mRNA technology

Overview

5

Research and development

5

COVID-19

6

Leading companies

4

Focus: Moderna

5

Focus: BioNTech

4

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu